Improvement in the detection of locoregional recurrence in head and neck malignancies: F‐18 fluorodeoxyglucose–positron emission tomography/computed tomography compared to high‐resolution contrast‐enhanced computed tomography and endoscopic examination

Authors:

Abstract
Objectives/Hypothesis: To compare the diagnostic efficacy of positron emission tomography (PET) with F‐18 fluorodeoxyglucose (FDG‐PET)/computed tomography (CT) to that of contrast‐enhanced high‐resolution CT (HRCT) and assess the value of a combinatorial approach in detection of recurrent squamous cell cancer of the head and neck (HNC) and to assess the efficacy of FDG‐PET/CT with and without HRCT in comparison to standard‐of‐care follow‐up—physical examination (PE) and endoscopy (E)—in determination of locally recurrent HNC.Study Design: Retrospective study.Methods: A total of 103 patients with HNC underwent FDG‐PET/CT and neck HRCT. There were two groups of patients: Group A had an FDG‐PET study acquired with low‐dose CT, and group B had an FDG‐PET study acquired with HRCT. The PET data obtained with or without HRCT were compared on a lesion and patient basis with the results of the PE/E.Results: On a lesion basis, both groups combined had higher sensitivity and negative predictive value (NPV) than the HRCT. Specificity and positive predictive value (PPV) for group B were higher than for group A. On a patient basis, both groups combined had a higher sensitivity and NPV than PE/E, respectively, although specificity of PE/E was higher than that of either group. PET data obtained with either protocol directly influenced treatment.Conclusions: HRCT increases the specificity and PPV of PET/CT when acquired simultaneously with PET. FDG‐PET/CT acquired with either LDCT or HRCT has higher accuracy than HRCT alone and increases the sensitivity and NPV of PE/E.Level of Evidence: 4 Laryngoscope, 123:2664–2669, 2013

This publication has 27 references indexed in Scilit: